Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Benjamin Looker currently holds 385,905 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benjamin Looker has been a net seller of ESPR stock. They have purchased $0 and sold $92.3K worth of shares.
Benjamin Looker's most recent insider trade was on Dec 17, 2025, when they sold 6,517 shares at $3.67 per share.
Benjamin Looker serves as Executive at Esperion Therapeutics, Inc. (ESPR). They have executed 10 insider transactions totaling $92.3K over their tenure at the company.
Benjamin Looker holds the position of Executive at Esperion Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Benjamin Looker has shown a selling trading pattern, with $0 in total purchases and $92.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Benjamin Looker was on Jan 18, 2023, when they sold $44.4K worth of ESPR shares. This transaction involved 6,347 shares at $7.00 per share.
Benjamin Looker currently owns 385,905 shares of Esperion Therapeutics, Inc. (ESPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Benjamin Looker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Benjamin Looker has 10 Form 4 filings on record as an insider at Esperion Therapeutics, Inc..
Set alerts for Benjamin Looker and 40,000+ other insiders.